Efficacy and tolerability of candesartan cilexetil in hypertensive, type II diabetic patients presenting with diabetic nephropathy (the 'decade' study)

被引：0
|
作者：
Mimran, A [1 ]
Nisse-Durgeat, S [1 ]
机构：
[1] Lapeyronie Hosp, Montpellier, France
来源：
JOURNAL OF HYPERTENSION | 2005年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S330 / S330
页数：1
相关论文
共 50 条
  • [31] Study of Irisin Hormone Level in Type 2 Diabetic Patients and Patients with Diabetic Nephropathy
    Shelbaya, Salah
    Abu Shady, Manal Mohamed
    Nasr, Merhan Samy
    Bekhet, Meram Mohamed
    Abd-Al Mageed, Yasmine
    Abbas, Magdy
    CURRENT DIABETES REVIEWS, 2018, 14 (05) : 481 - 486
  • [32] Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice
    Liao, J
    Kobayashi, M
    Kanamuru, Y
    Nakamura, S
    Makita, Y
    Funabiki, K
    Horikoshi, S
    Tomino, Y
    JOURNAL OF NEPHROLOGY, 2003, 16 (06) : 841 - 849
  • [33] Evaluation, efficacy and tolerability of GlucoNovax tablet in type 2 diabetic patients
    Ali, Zubair
    Daniyal, Muhammad
    Ismailov, S. I.
    Usmanghani, Khan
    Naveed, Safila
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 29 (04) : 1443 - 1449
  • [34] Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients
    Fogari, R
    Derosa, G
    Mugellini, A
    Preti, P
    Rinaldi, A
    Pasotti, C
    Malacco, E
    Corradi, L
    JOURNAL OF HYPERTENSION, 2003, 21 : S85 - S86
  • [35] Effect of amlodipine vs candesartan on left ventricular hypertrophy in hypertensive type 2 diabetic patients
    Fogari, R
    Preti, P
    Malacco, E
    Corradi, L
    Pasotti, C
    Rinaldi, A
    Zoppi, A
    Mugellini, A
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 87A - 87A
  • [36] Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy
    Andersen, S
    Tarnow, L
    Rossing, P
    Hansen, BV
    Parving, HH
    KIDNEY INTERNATIONAL, 2000, 57 (02) : 601 - 606
  • [37] Effect of amlodipine vs candesartan on left ventricular hypertrophy in hypertensive type 2 diabetic patients
    Fogari, R
    Preti, P
    Malacco, E
    Corradi, L
    Pasotti, C
    Rinaldi, A
    Zoppi, A
    Mugellini, A
    JOURNAL OF HYPERTENSION, 2003, 21 : S85 - S85
  • [38] Autoregulated glomerular filtration rate during candesartan treatment in hypertensive type 2 diabetic patients
    Christensen, PK
    Lund, S
    Parving, HH
    KIDNEY INTERNATIONAL, 2001, 60 (04) : 1435 - 1442
  • [39] Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients
    Fogari, R
    Derosa, G
    Mugellini, A
    Preti, P
    Rinaldi, A
    Pasotti, C
    Malacco, E
    Corradi, L
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 70A - 70A
  • [40] Effects of candesartan on urinary alubumin and protein excretion in the diabetic patients with nephropathy
    Hayashi, I
    Asakawa, H
    Fukui, T
    Tokunaga, K
    DIABETES, 2002, 51 : A513 - A513
12345